Antares Pharma to Present at William Blair Small-Cap Growth Stock Conference.EWING, N.J. -- Antares Pharma (AMEX AMEX See: American Stock Exchange :AIS), announced that Jack E. Stover, President & Chief Executive Officer, is scheduled to present at the William Blair & Company Small-Cap Growth Stock Conference on Wednesday October 3 at 9:20 pm (EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT ) at the Palace Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . A live webcast of the audio portion of this presentation will be available via http://www.wsw.com/webcast/blair9/antr.ob/ and can be replayed until January 3, 2007. About Antares Pharma Antares Pharma is a specialized pharma product development company committed to improving pharmaceuticals through its patented drug delivery systems. Antares has three validated drug delivery platforms: the ATD ATD Anthropomorphic Test Dummy ATD Attention to Detail ATD Advanced Technology Demonstration AtD Achieving the Dream ATD Atmospheric Technology Division (US National Center for Atmospheric Research) ATD Assistant Technical Director (TM) Advanced Transdermal Delivery system transdermal delivery system: see skin patch. , subcutaneous injection technology platforms including both Vibex(TM) disposable mini-needle injection device and Valeo(TM)/Vision[R] reusable needle-free injection devices; and Easy Tec(TM) oral fast-melt technology. Two of the platforms have generated FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approved products. Antares Pharma leverages its multiple drug delivery platforms to add value to existing drugs and to create new pharmaceutical products and injectable devices. The Company's products are engineered to improve safety and efficacy profiles by minimizing dosing and reducing side effects while enabling improved patient compliance. Antares Pharma has corporate headquarters in Ewing, New Jersey, with subsidiaries performing research, development, manufacturing and product commercialization activities in Minneapolis, Minnesota and Basel, Switzerland. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion